Literature DB >> 32025000

Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model.

Osamu Kikuchi1, Gina N Duronio1, Nilay S Sethi2,3,4, Matthew D Stachler1,5,6, James M McFarland7, Ruben Ferrer-Luna1,7, Yanxi Zhang1, Chunyang Bao1, Roderick Bronson8, Deepa Patil5, Francisco Sanchez-Vega9, Jie-Bin Liu1, Ewa Sicinska6, Jean-Bernard Lazaro10,11, Keith L Ligon1,7,6, Rameen Beroukhim1,7, Adam J Bass12,13,14.   

Abstract

Somatic alterations in cancer genes are being detected in normal and premalignant tissue, thus placing greater emphasis on gene-environment interactions that enable disease phenotypes. By combining early genetic alterations with disease-relevant exposures, we developed an integrative mouse model to study gastric premalignancy. Deletion of Trp53 in gastric cells confers a selective advantage and promotes the development of dysplasia in the setting of dietary carcinogens. Organoid derivation from dysplastic lesions facilitated genomic, transcriptional and functional evaluation of gastric premalignancy. Cell cycle regulators, most notably Cdkn2a, were upregulated by p53 inactivation in gastric premalignancy, serving as a barrier to disease progression. Co-deletion of Cdkn2a and Trp53 in dysplastic gastric organoids promoted cancer phenotypes but also induced replication stress, exposing a susceptibility to DNA damage response inhibitors. These findings demonstrate the utility of mouse models that integrate genomic alterations with relevant exposures and highlight the importance of gene-environment interactions in shaping the premalignant state.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32025000      PMCID: PMC7031028          DOI: 10.1038/s41588-019-0574-9

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  95 in total

1.  Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.

Authors:  Michael Quante; Govind Bhagat; Julian A Abrams; Frederic Marache; Pamela Good; Michele D Lee; Yoomi Lee; Richard Friedman; Samuel Asfaha; Zinaida Dubeykovskaya; Umar Mahmood; Jose-Luiz Figueiredo; Jan Kitajewski; Carrie Shawber; Charles J Lightdale; Anil K Rustgi; Timothy C Wang
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

2.  Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis.

Authors:  K Yang; W Edelmann; K Fan; K Lau; D Leung; H Newmark; R Kucherlapati; M Lipkin
Journal:  Cancer Res       Date:  1998-12-15       Impact factor: 12.701

3.  Nitrosamines as environmental carcinogens.

Authors:  W Lijinsky; S S Epstein
Journal:  Nature       Date:  1970-01-03       Impact factor: 49.962

4.  Effects of bile reflux on gastric mucosal lesions in patients with dyspepsia or chronic gastritis.

Authors:  Sheng-Liang Chen; Jian-Zhong Mo; Zhi-Jun Cao; Xiao-Yu Chen; Shu-Dong Xiao
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

5.  Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing.

Authors:  Hiroyuki Tomita; Shigeo Takaishi; Trevelyan R Menheniott; Xiangdong Yang; Wataru Shibata; Guangchun Jin; Kelly S Betz; Kazuyuki Kawakami; Toshinari Minamoto; Catherine Tomasetto; Marie-Christine Rio; Nataporn Lerkowit; Andrea Varro; Andrew S Giraud; Timothy C Wang
Journal:  Gastroenterology       Date:  2010-11-25       Impact factor: 22.682

Review 6.  Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence.

Authors:  Veronique Giroux; Anil K Rustgi
Journal:  Nat Rev Cancer       Date:  2017-09-01       Impact factor: 60.716

7.  Ursodeoxycholic acid treatment of bile reflux gastritis.

Authors:  A B Stefaniwsky; G S Tint; J Speck; S Shefer; G Salen
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

Review 8.  Chemotherapy for advanced gastric cancer.

Authors:  Anna Dorothea Wagner; Nicholas Lx Syn; Markus Moehler; Wilfried Grothe; Wei Peng Yong; Bee-Choo Tai; Jingshan Ho; Susanne Unverzagt
Journal:  Cochrane Database Syst Rev       Date:  2017-08-29

9.  Bile reflux and intestinal metaplasia in gastric mucosa.

Authors:  G M Sobala; H J O'Connor; E P Dewar; R F King; A T Axon; M F Dixon
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

10.  Cell-of-origin chromatin organization shapes the mutational landscape of cancer.

Authors:  Paz Polak; Rosa Karlić; Amnon Koren; Robert Thurman; Richard Sandstrom; Michael Lawrence; Alex Reynolds; Eric Rynes; Kristian Vlahoviček; John A Stamatoyannopoulos; Shamil R Sunyaev
Journal:  Nature       Date:  2015-02-19       Impact factor: 49.962

View more
  16 in total

1.  New markers and models of premalignancy and the early development of gastric cancer.

Authors:  Katrina Ray
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04       Impact factor: 46.802

Review 2.  Mapping the genomic diaspora of gastric cancer.

Authors:  Khay Guan Yeoh; Patrick Tan
Journal:  Nat Rev Cancer       Date:  2021-10-26       Impact factor: 60.716

3.  Early TP53 Alterations Shape Gastric and Esophageal Cancer Development.

Authors:  Pranshu Sahgal; Brandon M Huffman; Deepa T Patil; Walid K Chatila; Rona Yaeger; James M Cleary; Nilay S Sethi
Journal:  Cancers (Basel)       Date:  2021-11-24       Impact factor: 6.575

4.  miR‑486‑5p suppresses gastric cancer cell growth and migration through downregulation of fibroblast growth factor 9.

Authors:  Weiwei Wei; Chunyu Liu; Rongrong Yao; Qingyun Tan; Qingdong Wang; Hao Tian
Journal:  Mol Med Rep       Date:  2021-09-07       Impact factor: 2.952

Review 5.  It's Getting Complicated-A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy.

Authors:  Che-Pei Kung; Jason D Weber
Journal:  Front Cell Dev Biol       Date:  2022-01-26

6.  Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis.

Authors:  Paola Ulivi; Luca Saragoni; Chiara Molinari; Gianluca Tedaldi; Francesca Rebuzzi; Paolo Morgagni; Laura Capelli; Sara Ravaioli; Maria Maddalena Tumedei; Emanuela Scarpi; Anna Tomezzoli; Riccardo Bernasconi; Maria Raffaella Ambrosio; Alessia D'Ignazio; Leonardo Solaini; Francesco Limarzi; Giorgio Ercolani; Giovanni Martinelli
Journal:  Gastric Cancer       Date:  2020-11-06       Impact factor: 7.370

Review 7.  Stem cells and origins of cancer in the upper gastrointestinal tract.

Authors:  Yoku Hayakawa; Hiroshi Nakagawa; Anil K Rustgi; Jianwen Que; Timothy C Wang
Journal:  Cell Stem Cell       Date:  2021-06-14       Impact factor: 25.269

8.  Prognostic values of GPNMB identified by mining TCGA database and STAD microenvironment.

Authors:  Kunhou Yao; Lunshou Wei; Junjie Zhang; Chenyu Wang; Chaoyang Wang; Changjiang Qin; Song Li
Journal:  Aging (Albany NY)       Date:  2020-08-21       Impact factor: 5.682

Review 9.  Generation of Human Stomach Cancer iPSC-Derived Organoids Induced by Helicobacter pylori Infection and Their Application to Gastric Cancer Research.

Authors:  Chia-Chen Ku; Kenly Wuputra; Jia-Bin Pan; Chia-Pei Li; Chung-Jung Liu; Yi-Chang Liu; Shigeo Saito; Te-Fu Chan; Chang-Shen Lin; Deng-Chyang Wu; Kazunari K Yokoyama
Journal:  Cells       Date:  2022-01-06       Impact factor: 6.600

10.  Protocol for chemically induced murine gastric tumor model.

Authors:  Ke Li; Ao Wang; Huijuan Liu; Baojie Li
Journal:  STAR Protoc       Date:  2021-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.